Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Scarsdale Equities Morning Technical Note

Published 01/14/2015, 08:34 AM
Updated 07/09/2023, 06:31 AM

Intraday Rallies Fail

SPX Forward 12 Month EPS Estimates Lowered

Opinion: Although no support or resistance levels were violated on a closing basis yesterday, the notable intraday rallies failed with all of the indexes closing lower on the day on increasing volumes. As there is no strong supportive evidence coming from the data, the near term neutral outlook has turned more cautionary. The combination of active insider selling with SPX forward estimates declining again leaves us still cautionary on the intermediate term.

  • On the charts, yesterday’s gyrations saw an unusual performance as the majority of the indexes tested both their resistance and support levels on an intraday basis. The final result was negative as all of the indexes closed lower with the SPX (page 2) closing below its short term uptrend line from the October lows along with the DJT (page 3). No support levels were violated but the complete give up of the intraday gains is negative in our view. Trading volumes increased with negative internals adding to the poor performance.
  • The data remains largely neutral. The McClellan OB/OS Oscillators are all neutral (NYSE:-23.98/+18.16 NASDAQ:-31.25/-6.06) giving no oversold signals. Both the Equity and OEX Put/Call Ratios are neutral as well along with the WST Ratio and its Composite (40.1/108.8). As such, there appears to be little evidence suggestive of a bounce.
  • Sentiment remains disturbing as the Gambill Insider Buy/Sell Ratio shows insiders as remaining active sellers at 6.1 while the leveraged ETF traders have pressed their leveraged long bets close to a new extended high of 68.7 on the Rydex Ratio (contrary indicator). This split between insiders and the crowd remains troublesome, in our view.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  • Finally after raising forward 12 month earnings estimates for the SPX a few days ago, First Call has now lowered them again from $126.66 to $126.07. We view this as another cloud overhanging intermediate term prospects for the markets in general.
  • For the longer term, we remain bullish on equities as they remain comparatively undervalued with a 6.23% forward earnings yield for the SPX based on 12 month IBES forward earnings estimates of $126.07 versus the US 10 Year Treasury yield of 1.89%.

SPX: 2,002/2,061

Dow Jones 30: 17,578/17,964

NASDAQ Composite: 4,650/4,733

Dow Jones Transportation: 8,656/8,995

S&P Midcap 400:1,424/1,458

Russell 2000:1,156/1,199

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.